Financhill
Sell
34

IQV Quote, Financials, Valuation and Earnings

Last price:
$153.30
Seasonality move :
13.67%
Day range:
$146.72 - $153.69
52-week range:
$135.97 - $252.88
Dividend yield:
0%
P/E ratio:
20.89x
P/S ratio:
1.80x
P/B ratio:
4.44x
Volume:
2.9M
Avg. volume:
2.2M
1-year change:
-33.1%
Market cap:
$26.5B
Revenue:
$15.4B
EPS (TTM):
$7.34
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $11.4B $13.9B $14.4B $15B $15.4B
Revenue Growth (YoY) 2.44% 22.14% 3.86% 3.98% 2.81%
 
Cost of Revenues $7.5B $9.2B $9.4B $9.7B $10B
Gross Profit $3.9B $4.6B $5B $5.2B $5.4B
Gross Profit Margin 33.97% 33.45% 34.89% 34.96% 34.89%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.8B $2B $2.1B $2.1B $2B
Other Inc / (Exp) -- $84M -$61M $34M $23M
Operating Expenses $3.1B $3.2B $3.2B $3.2B $3.1B
Operating Income $783M $1.4B $1.8B $2.1B $2.3B
 
Net Interest Expenses $410M $369M $403M $636M $623M
EBT. Incl. Unusual Items $373M $1.1B $1.4B $1.5B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $72M $163M $260M $101M $301M
Net Income to Company $308M $971M $1.1B $1.4B $1.4B
 
Minority Interest in Earnings -$29M -$5M -- -- --
Net Income to Common Excl Extra Items $279M $966M $1.1B $1.4B $1.4B
 
Basic EPS (Cont. Ops) $1.46 $5.05 $5.82 $7.39 $7.57
Diluted EPS (Cont. Ops) $1.43 $4.95 $5.72 $7.29 $7.49
Weighted Average Basic Share $191.3M $191.4M $187.6M $183.8M $181.3M
Weighted Average Diluted Share $195M $195M $190.6M $186.3M $183.4M
 
EBITDA $2.1B $2.8B $2.9B $3.3B $3.5B
EBIT $789M $1.5B $1.8B $2.1B $2.3B
 
Revenue (Reported) $11.4B $13.9B $14.4B $15B $15.4B
Operating Income (Reported) $783M $1.4B $1.8B $2.1B $2.3B
Operating Income (Adjusted) $789M $1.5B $1.8B $2.1B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.4B $3.6B $3.7B $3.7B $3.8B
Revenue Growth (YoY) 23.78% 4.66% 2.35% 2.33% 2.46%
 
Cost of Revenues $2.3B $2.3B $2.4B $2.4B $2.5B
Gross Profit $1.1B $1.2B $1.3B $1.3B $1.3B
Gross Profit Margin 32.74% 34.89% 34.34% 34.6% 33.9%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $442M $488M $513M $508M $508M
Other Inc / (Exp) $4M -$17M $9M -$26M -$48M
Operating Expenses $765M $743M $766M $772M $773M
Operating Income $351M $502M $488M $521M $525M
 
Net Interest Expenses $98M $85M $135M $155M $154M
EBT. Incl. Unusual Items $257M $400M $362M $340M $323M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $44M $71M $71M $49M $61M
Net Income to Company $217M $325M $289M $288M $249M
 
Minority Interest in Earnings -$5M -- -- -- --
Net Income to Common Excl Extra Items $212M $325M $289M $288M $249M
 
Basic EPS (Cont. Ops) $1.11 $1.71 $1.56 $1.58 $1.42
Diluted EPS (Cont. Ops) $1.09 $1.68 $1.53 $1.56 $1.40
Weighted Average Basic Share $191.5M $190M $185.8M $181.9M $175.7M
Weighted Average Diluted Share $194.9M $193.4M $188.6M $184.3M $177.4M
 
EBITDA $679M $741M $756M $770M $753M
EBIT $356M $486M $503M $506M $488M
 
Revenue (Reported) $3.4B $3.6B $3.7B $3.7B $3.8B
Operating Income (Reported) $351M $502M $488M $521M $525M
Operating Income (Adjusted) $356M $486M $503M $506M $488M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $12B $14B $14.5B $15.1B $15.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8B $9.3B $9.5B $9.8B $10.1B
Gross Profit $4B $4.8B $5B $5.3B $5.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.8B $2B $2.1B $2B $2B
Other Inc / (Exp) $2M $63M -$35M -$1M $1M
Operating Expenses $3.1B $3.2B $3.2B $3.2B $3.1B
Operating Income $927M $1.6B $1.8B $2.1B $2.3B
 
Net Interest Expenses $404M $356M $453M $656M $622M
EBT. Incl. Unusual Items $528M $1.3B $1.3B $1.4B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $99M $190M $260M $79M $313M
Net Income to Company $434M $1.1B $1.1B $1.4B $1.3B
 
Minority Interest in Earnings -$25M -- -- -- --
Net Income to Common Excl Extra Items $409M $1.1B $1.1B $1.4B $1.3B
 
Basic EPS (Cont. Ops) $2.14 $5.65 $5.66 $7.43 $7.42
Diluted EPS (Cont. Ops) $2.10 $5.55 $5.56 $7.32 $7.34
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.2B $2.8B $2.9B $3.3B $3.4B
EBIT $937M $1.6B $1.8B $2.1B $2.3B
 
Revenue (Reported) $12B $14B $14.5B $15.1B $15.5B
Operating Income (Reported) $927M $1.6B $1.8B $2.1B $2.3B
Operating Income (Adjusted) $937M $1.6B $1.8B $2.1B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $3.4B $3.6B $3.7B $3.7B $3.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.3B $2.3B $2.4B $2.4B $2.5B
Gross Profit $1.1B $1.2B $1.3B $1.3B $1.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $442M $488M $513M $508M $508M
Other Inc / (Exp) $4M -$17M $9M -$26M -$48M
Operating Expenses $765M $743M $766M $772M $773M
Operating Income $351M $502M $488M $521M $525M
 
Net Interest Expenses $98M $85M $135M $155M $154M
EBT. Incl. Unusual Items $257M $400M $362M $340M $323M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $44M $71M $71M $49M $61M
Net Income to Company $217M $325M $289M $288M $249M
 
Minority Interest in Earnings -$5M -- -- -- --
Net Income to Common Excl Extra Items $212M $325M $289M $288M $249M
 
Basic EPS (Cont. Ops) $1.11 $1.71 $1.56 $1.58 $1.42
Diluted EPS (Cont. Ops) $1.09 $1.68 $1.53 $1.56 $1.40
Weighted Average Basic Share $191.5M $190M $185.8M $181.9M $175.7M
Weighted Average Diluted Share $194.9M $193.4M $188.6M $184.3M $177.4M
 
EBITDA $679M $741M $756M $770M $753M
EBIT $356M $486M $503M $506M $488M
 
Revenue (Reported) $3.4B $3.6B $3.7B $3.7B $3.8B
Operating Income (Reported) $351M $502M $488M $521M $525M
Operating Income (Adjusted) $356M $486M $503M $506M $488M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.8B $1.4B $1.2B $1.4B $1.7B
Short Term Investments $88M $111M $93M $120M $141M
Accounts Receivable, Net $1.2B $1.3B $1.3B $1.5B $1.4B
Inventory -- -- -- -- --
Prepaid Expenses $159M $156M $151M $141M $154M
Other Current Assets $563M $521M $561M $546M $592M
Total Current Assets $5.1B $4.8B $5B $5.6B $5.8B
 
Property Plant And Equipment $953M $903M $863M $819M $773M
Long-Term Investments $162M $164M $162M $239M $374M
Goodwill $12.7B $13.3B $13.9B $14.6B $14.7B
Other Intangibles $5.2B $4.9B $4.8B $4.8B $4.5B
Other Long-Term Assets $386M $491M $472M $455M $520M
Total Assets $24.6B $24.7B $25.3B $26.7B $26.9B
 
Accounts Payable $581M $621M $645M $709M $736M
Accrued Expenses $1.4B $1.4B $1.7B $1.9B $2B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $242M $207M $152M $294M $193M
Total Current Liabilities $4.6B $5.2B $5.6B $6.5B $7B
 
Long-Term Debt $12.4B $12B $12.6B $13B $12.8B
Capital Leases -- -- -- -- --
Total Liabilities $18.3B $18.6B $19.6B $20.6B $20.8B
 
Common Stock $11.1B $3M $10.9B $3M $3M
Other Common Equity Adj -$205M -$406M -$727M -$867M -$1B
Common Equity $6B $6B $5.8B $6.1B $6.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $279M -- -- -- --
Total Equity $6.3B $6B $5.8B $6.1B $6.1B
 
Total Liabilities and Equity $24.6B $24.7B $25.3B $26.7B $26.9B
Cash and Short Terms $1.9B $1.5B $1.3B $1.5B $1.8B
Total Debt $12.5B $12.1B $12.7B $13.7B $14B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $2.3B $1.4B $1.5B $1.4B $1.7B
Short Term Investments $97M $106M $104M $131M $136M
Accounts Receivable, Net $1.2B $1.2B $1.4B $1.4B $1.4B
Inventory -- -- -- -- --
Prepaid Expenses $159M $162M $165M $173M $166M
Other Current Assets $593M $455M $460M $442M $558M
Total Current Assets $5.6B $4.8B $5.3B $5.7B $5.9B
 
Property Plant And Equipment $909M $938M $845M $791M $768M
Long-Term Investments $162M $162M $201M $263M $383M
Goodwill $12.4B $13.5B $14B $14.5B $15B
Other Intangibles $4.9B $4.9B $4.8B $4.7B $4.5B
Other Long-Term Assets $380M $528M $468M $476M $485M
Total Assets $24.5B $25B $25.7B $26.6B $27.3B
 
Accounts Payable $2.8B $2.8B $3.1B $3.5B $3.6B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $216M $189M $157M $207M $319M
Total Current Liabilities $4.9B $5.2B $6.7B $6.4B $7.2B
 
Long-Term Debt $12.1B $12.5B $11.8B $12.8B $13.1B
Capital Leases -- -- -- -- --
Total Liabilities $18.2B $19.1B $19.8B $20.2B $21.3B
 
Common Stock $11.1B $10.7B $10.9B $11B $3M
Other Common Equity Adj -$376M -$419M -$731M -$911M -$978M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $284M -- -- -- $8M
Total Equity $6.2B $5.9B $5.9B $6.3B $6B
 
Total Liabilities and Equity $24.5B $25B $25.7B $26.6B $27.3B
Cash and Short Terms $2.4B $1.5B $1.6B $1.6B $1.9B
Total Debt $12.2B $12.6B $13.2B $13.5B $14.3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $308M $971M $1.1B $1.4B $1.4B
Depreciation & Amoritzation $1.3B $1.3B $1.1B $1.1B $1.1B
Stock-Based Compensation $95M $170M $194M $217M $206M
Change in Accounts Receivable $255M -$138M -$421M -$388M $182M
Change in Inventories -- -- -- -- --
Cash From Operations $2B $2.9B $2.3B $2.1B $2.7B
 
Capital Expenditures $616M $640M $674M $649M $602M
Cash Acquisitions -$167M -$1.5B -$1.3B -$915M -$867M
Cash From Investing -$796M -$2.1B -$2B -$1.6B -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.8B $2.8B $3.6B $6.4B $1.7B
Long-Term Debt Repaid -$2.5B -$2.7B -$2.7B -$5.6B -$1.1B
Repurchase of Common Stock -$447M -$406M -$1.2B -$992M -$1.4B
Other Financing Activities -$68M -$840M -$31M -$131M -$17M
Cash From Financing -$217M -$1.2B -$329M -$382M -$878M
 
Beginning Cash (CF) $837M $1.8B $1.4B $1.2B $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $946M -$396M -$75M $164M $394M
Ending Cash (CF) $1.8B $1.4B $1.2B $1.4B $1.7B
 
Levered Free Cash Flow $1.3B $2.3B $1.6B $1.5B $2.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $217M $325M $289M $288M $249M
Depreciation & Amoritzation $323M $255M $253M $264M $265M
Stock-Based Compensation $32M $30M $75M $56M $72M
Change in Accounts Receivable $342M $54M -$107M $65M $128M
Change in Inventories -- -- -- -- --
Cash From Operations $867M $508M $417M $522M $568M
 
Capital Expenditures $149M $177M $164M $145M $142M
Cash Acquisitions -$20M -$436M -$25M -$166M -$147M
Cash From Investing -$176M -$613M -$222M -$314M -$305M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.8B $950M $475M $275M $2.3B
Long-Term Debt Repaid -$1.8B -$324M -$139M -$318M -$2.1B
Repurchase of Common Stock -$62M -$403M -$129M -- -$375M
Other Financing Activities -$43M -$12M -$62M -$3M -$12M
Cash From Financing -$168M $144M $87M -$106M -$258M
 
Beginning Cash (CF) $1.8B $1.4B $1.2B $1.4B $1.7B
Foreign Exchange Rate Adjustment -$32M -$18M -$4M -$34M $33M
Additions / Reductions $523M $39M $282M $102M $5M
Ending Cash (CF) $2.3B $1.4B $1.5B $1.4B $1.7B
 
Levered Free Cash Flow $718M $331M $253M $377M $426M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $434M $1.1B $1.1B $1.4B $1.3B
Depreciation & Amoritzation $1.3B $1.2B $1.1B $1.1B $1.1B
Stock-Based Compensation $127M $168M $239M $198M $222M
Change in Accounts Receivable $681M -$426M -$582M -$216M $245M
Change in Inventories -- -- -- -- --
Cash From Operations $2.7B $2.6B $2.2B $2.3B $2.8B
 
Capital Expenditures $624M $668M $661M $630M $599M
Cash Acquisitions -$190M -$1.9B -$924M -$1.1B -$848M
Cash From Investing -$822M -$2.5B -$1.6B -$1.7B -$1.4B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.8B $2B $3.1B $6.2B $3.7B
Long-Term Debt Repaid -$3B -$1.3B -$2.5B -$5.8B -$2.9B
Repurchase of Common Stock -$164M -$747M -$894M -$863M -$1.7B
Other Financing Activities -$89M -$809M -$81M -$72M -$26M
Cash From Financing -$492M -$923M -$386M -$575M -$1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.3B -$880M $168M -$16M $297M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2B $1.9B $1.5B $1.6B $2.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $217M $325M $289M $288M $249M
Depreciation & Amoritzation $323M $255M $253M $264M $265M
Stock-Based Compensation $32M $30M $75M $56M $72M
Change in Accounts Receivable $342M $54M -$107M $65M $128M
Change in Inventories -- -- -- -- --
Cash From Operations $867M $508M $417M $522M $568M
 
Capital Expenditures $149M $177M $164M $145M $142M
Cash Acquisitions -$20M -$436M -$25M -$166M -$147M
Cash From Investing -$176M -$613M -$222M -$314M -$305M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.8B $950M $475M $275M $2.3B
Long-Term Debt Repaid -$1.8B -$324M -$139M -$318M -$2.1B
Repurchase of Common Stock -$62M -$403M -$129M -- -$375M
Other Financing Activities -$43M -$12M -$62M -$3M -$12M
Cash From Financing -$168M $144M $87M -$106M -$258M
 
Beginning Cash (CF) $1.8B $1.4B $1.2B $1.4B $1.7B
Foreign Exchange Rate Adjustment -$32M -$18M -$4M -$34M $33M
Additions / Reductions $523M $39M $282M $102M $5M
Ending Cash (CF) $2.3B $1.4B $1.5B $1.4B $1.7B
 
Levered Free Cash Flow $718M $331M $253M $377M $426M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 26.32% over the past day.

Buy
52
SRPT alert for May 8

Sarepta Therapeutics [SRPT] is down 0.98% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is down 0.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock